Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Cytotherapy|July 13, 2011
Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemiaFatma Visal Okur, Eric Yvon, Ettore Biagi, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 19, 2013
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosisMirco Belingheri, Lorenza Lazzari, Valentina Parazzi, et al.
British Journal of Haematology|February 26, 2013
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptorSarah Tettamanti, Virna Marin, Irene Pizzitola, et al.
Stem Cells International|June 16, 2012
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantationGiovanna Lucchini, Erica Dander, Fabio Pavan, et al.
Molecular Cancer|November 20, 2009
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regressionAaron E Foster, Fatma V Okur, Ettore Biagi, et al.
Oncotarget|June 21, 2016
Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platformChiara F Magnani, Nice Turazzi, Fabrizio Benedicenti, et al.
Cytotherapy|May 23, 2009
The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCsChiara Capelli, Agnese Salvade, Olga Pedrini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemiaEttore Biagi, Raphael Rousseau, Eric Yvon, et al.
Journal of Cellular and Molecular Medicine|July 25, 2009
GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapyGiuseppe Gaipa, Manuela Tilenni, Stefania Straino, et al.
Blood|March 17, 2011
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptorGreta Maria Paola Giordano Attianese, Virna Marin, Valentina Hoyos, et al.
Pageof 6